Breast Cancer Clinical Trial
Official title:
Efficacy of a Web-based Self-management Exercise and Diet Intervention Program With Tailored Motivation and Action Planning for Breast Cancer Survivors: A Randomized Controlled Trial
| Verified date | April 2014 |
| Source | National Cancer Center, Korea |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Korea: Food and Drug Administration |
| Study type | Interventional |
Life style interventions that promote exercise and a healthy diet, which have the potential
to improve health-related quality of life (HRQOL), may be particularly appropriate for
cancer survivors. The previous studies suggested that a key strategy to implement
sustainable healthy behavior and improve health was providing appropriate feedback and
promoting self-efficacy. Web-based program enables to provide the feedback in a timely
manner on a daily basis, to continue the healthy behaviors.
Therefore, the investigators developed a web-based, stage-matched Exercise and Diet Planning
program, and whether the program can promote significantly greater changes in behavioral
outcomes [goal of exercise (energy expenditure of aerobic exercise ≥ 12.5 kcal/kg/week) and
diet (intake of vegetables ≥ 5 serv/day and intake of fruit ≥ 1 serv/day)], stage of changes
for exercise and diet, psychosocial outcomes (HRQOL, fatigue, anxiety and depression) and
self-efficacy in implementing goal of exercise and diet among breast cancer survivors in
Korea was examined.
Hypotheses were following:
1. Survivors of a group participating in a web-based, stage-matched Exercise and Diet
Planning program (hereinafter called the 'intervention group') will show a more
advanced stage of change for exercise and diet compared to survivors in the control
group.
2. The intervention group will show a higher proportion of attaining goal of exercise (or
higher level of energy expenditure of aerobic exercise) compared to the control group.
3. The intervention group will show a higher proportion of attaining goal of diet (or
higher level of diet quality) compared to the control group.
4. The intervention group will show a better HRQOL level compared to the control group.
5. The intervention group will show a better self-efficacy level compared to the control
group.
6. The intervention group will show a lower fatigue level compared to the control group.
7. The intervention group will show less anxiety compared to the control group.
8. The intervention group will show less depression compared to the control group.
| Status | Completed |
| Enrollment | 59 |
| Est. completion date | August 2012 |
| Est. primary completion date | March 2012 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 20 Years and older |
| Eligibility |
Inclusion Criteria: 1. Women aged 20 years and older 2. Histologically confirmed stage 0 to III breast cancer who received curative breast cancer surgery within 12 months since completion of primary cancer treatment and 2 years since diagnosis 3. Serum platelet = 100,000/mm3 4. Serum hemoglobin = 10g/dl 5. Not met one or more behavior goals: i) energy expenditure of aerobic exercise = 12.5 kcal/kg/week; ii) intake of vegetables except kimchi = 5 serv/day and intake of fruit 1-2 serv/day; iii) maintenance of healthy weight (18.5 kg/m2 = BMI < 23 kg/m2) 6. Ability to use internet, and being accessible internet at home 7. Mobile phone user 8. Consent form to participate in the study Exclusion Criteria: 1. Currently receiving any cancer treatment 2. Conditions that could limit adherence to an unsupervised exercise program such as uncontrolled congestive heart failure or angina, recent myocardial infarction, or breathing difficulties requiring oxygen use or hospitalization; walker or wheelchair use; or plans to have hip or knee replacement 3. Conditions that could interfere with a high vegetable and fruit diet, such as kidney failure or chronic warfarin use 4. Progressive malignant disease or additional primary cancers 5. Infectious condition (body temperature = 37.2? or WBC = 11,000mm3) 6. Inability to use computer or internet 7. Visual and motor dysfunction |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| Korea, Republic of | National Cancer Center | Gyenggi-do | Goyang-si |
| Korea, Republic of | Asan Medical Center | Seoul | |
| Korea, Republic of | Korea University Anam Hospital | Seoul | |
| Korea, Republic of | Seoul National University | Seoul |
| Lead Sponsor | Collaborator |
|---|---|
| National Cancer Center, Korea | Asan Medical Center, Korea University Anam Hospital, Seoul National University |
Korea, Republic of,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change from baseline in numbers of goal behaviors at 3 months | The primary outcomes of the study are to achieve goals of healthy behaviors as followed: i) exercising=12.5kcal/kg/week; ii) eating vegetables=5serv/day and fruits 1-2 serv/day; iii) healthy weight (18.5kg/m2 = BMI < 25kg/m2) The primary outcome of the study is the increased number of goal behaviors. |
Baseline (pre-treatment) and after 12 weeks of intervention (post-treatment) | Yes |
| Secondary | Change from baseline in Stage of Change at 3 months | Stage of motivational readiness for exercise and diet based on the established TTM | Baseline, 1month, 2 month, 3 month after starting the intervention | Yes |
| Secondary | Change from baseline in self-efficacy at 3 months | The self-efficacy for exercising=12.5kcal/kg/week, eating vegetables=5serv/day and fruits 1-2 serv/day | Baseline, 1month, 2 month, 3 month after starting the intervention | Yes |
| Secondary | Change from baseline in psychosocial outcomes at 3 months | The psychosocial outcomes are HRQOL, fatigue, anxiety and depression | Baseline, 1month, 2 month, 3 month after starting the intervention | Yes |
| Secondary | Change from baseline in Diet quality at 3 months | Diet quality based on a three-day diet recall and the Diet Quality Index (DQI) revised for the Korean population | Baseline, 1month, 2 month, 3 month after starting the intervention | Yes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |